---
title: "On April 15th, SIMCERE PHARMA spent HKD 9.5732 million to repurchase 1.21 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236078224.md"
description: "According to the Zhitong Finance APP, SIMCERE PHARMA announced that on April 15, 2025, the company spent HKD 9.5732 million to repurchase 1.21 million shares, with a repurchase price of HKD 7.8100-7.9692 per share"
datetime: "2025-04-15T14:18:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236078224.md)
  - [en](https://longbridge.com/en/news/236078224.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236078224.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/236078224.md) | [繁體中文](https://longbridge.com/zh-HK/news/236078224.md)


# On April 15th, SIMCERE PHARMA spent HKD 9.5732 million to repurchase 1.21 million shares

According to the Zhitong Finance APP, SIMCERE PHARMA (02096) announced that on April 15, 2025, the company spent HKD 9.5732 million to repurchase 1.21 million shares, with a repurchase price ranging from HKD 7.8100 to HKD 7.9692 per share

### Related Stocks

- [SIMCERE PHARMA (02096.HK)](https://longbridge.com/en/quote/02096.HK.md)

## Related News & Research

- [Simcere Pharmaceutical Presents Bladder Cancer Drug Trial Results at European Urology Conference](https://longbridge.com/en/news/279439171.md)
- [Styland Subsidiary Commits US$3.4 Million to Alpha Perpetual Income Fund](https://longbridge.com/en/news/281380835.md)
- [Ubtech Robotics Narrows Loss in 2025](https://longbridge.com/en/news/281187944.md)
- [PetroChina Renews Financial Deal With Related Company](https://longbridge.com/en/news/280998322.md)
- [3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady](https://longbridge.com/en/news/281054154.md)